These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27614572)

  • 1. Corrigendum to "Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance" [Int. J. Cardiol. 202 (2016) 76-77].
    Caminiti G; Fossati C; Rosano G; Volterrani M
    Int J Cardiol; 2016 Nov; 223():1077. PubMed ID: 27614572
    [No Abstract]   [Full Text] [Related]  

  • 2. Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance.
    Caminiti G; Fossati C; Rosano G; Volterrani M
    Int J Cardiol; 2016 Jan; 202():73-4. PubMed ID: 26386926
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Height is associated with incident atrial fibrillation in a large Asian cohort", [Int. J. Cardiol. 304C, (2020) 82-84].
    Park YM; Moon J; Hwang IC; Lim H; Cho B
    Int J Cardiol; 2020 Jun; 309():93-94. PubMed ID: 32223965
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Contribution of central and peripheral factors at peak exercise in heart failure patients with progressive severity of exercise limitation." [Int. J. Cardiol. 248 (2017) 252-256].
    Del Torto A; Corrieri N; Vignati C; Gentile P; Cattadori G; Paolillo S; Agostoni P
    Int J Cardiol; 2018 Feb; 253():198. PubMed ID: 29249469
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Ivabradine as adjuvant treatment for chronic heart failure" [Int. J. Cardiol. 227 (2017) 43-50].
    Mizzaci CC; Porfírio GJM; Vilela AT; Guillhen JCS; Riera R
    Int J Cardiol; 2017 Nov; 247():55. PubMed ID: 28916091
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs.
    Uemura K; Inagaki M; Zheng C; Kawada T; Li M; Fukumitsu M; Sugimachi M
    Heart Vessels; 2017 Apr; 32(4):484-494. PubMed ID: 27844147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of ivabradine on heart rate during maximal efforts in a woman with permanent atrial fibrillation.
    Fossati C; Volterrani M; Punzo N; Campolongo G; Cascelli G; Caminiti G
    Int J Cardiol; 2017 Nov; 247():37. PubMed ID: 28916075
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Exercise-based cardiac rehabilitation in twelve European countries: Results of the European Cardiac Rehabilitation Registry" [Int. J. Cardiol. 228 (2017) 58-67].
    Benzer W; Rauch B; Schmid JP; Zwisler AD; Dendale P; Davos CH; Kouidi E; Simon A; Abreu A; Pogosova N; Gaita D; Miletic B; Bönner G; Ouarrak T; McGee H;
    Int J Cardiol; 2017 Sep; 242():50. PubMed ID: 28558920
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging role of ivabradine for rate control in atrial fibrillation.
    Turley SL; Francis KE; Lowe DK; Cahoon WD
    Ther Adv Cardiovasc Dis; 2016 Dec; 10(6):348-352. PubMed ID: 27659287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits of ivabradine are independent of resting heart rate.
    Riccioni G
    Future Cardiol; 2013 May; 9(3):313-5. PubMed ID: 23668736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Small, unrepaired ventricular septal defects reveal poor exercise capacity compared with healthy peers: A prospective, cohort study" [Int. J. Cardiol. 227 (2017) 631-634].
    Maagaard M; Heiberg J; Hjortdal VE
    Int J Cardiol; 2017 Nov; 247():54. PubMed ID: 28734573
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to Positive pediatric exercise capacity trajectory predicts better adult Fontan physiology: Rationale for early establishment of exercise habits Int. J. Cardiol. (2019), 274, 80-87.
    Ohuchi H; Negishi J; Miike H; Toyoshima Y; Morimoto Y; Fukuyama M; Iwasa T; Sakaguchi H; Miyazaki A; Shiraishi I; Kurosaki K; Nakai M
    Int J Cardiol; 2021 Jan; 323():271. PubMed ID: 33067022
    [No Abstract]   [Full Text] [Related]  

  • 13. Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation.
    Wongcharoen W; Ruttanaphol A; Gunaparn S; Phrommintikul A
    Int J Cardiol; 2016 Dec; 224():252-255. PubMed ID: 27661415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Mismatch between right- and left-sided filling pressures in heart failure patients with preserved ejection fraction" [Int. J. Cardiol. 257 (2018) 143-149].
    Horiuchi Y; Tanimoto S; Aoki J; Fuse N; Yahagi K; Koseki K; Okuno T; Nakajima H; Hara K; Tanabe K
    Int J Cardiol; 2018 Sep; 267():217. PubMed ID: 29731351
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Lung ultrasound predicts decompensation in heart failure outpatients: Another piece to the puzzle but still an incomplete picture" [Int. J. Cardiol. 240 (2017) 324-325].
    Agricola E; Marini C
    Int J Cardiol; 2017 Dec; 248():440. PubMed ID: 28859840
    [No Abstract]   [Full Text] [Related]  

  • 17. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation.
    Verrier RL; Bonatti R; Silva AF; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L
    Heart Rhythm; 2014 Dec; 11(12):2288-96. PubMed ID: 25111327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to 'Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology' [Int. J. Cardiol. 220 (2016) 131-136].
    Ertekin E; van Hagen IM; Salam AM; Ruys TP; Johnson MR; Popelova J; Parsonage WA; Ashour Z; Shotan A; Oliver JM; Veldtman GR; Hall R; Roos-Hesselink JW
    Int J Cardiol; 2017 Apr; 232():348. PubMed ID: 28139301
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Letter to correlation between pulmonary artery pressure and thoracic impedance: Insights from dailymonitoring through an implanted device in chronic heart failure" [Int. J. Cardiol. 245 (2017) 196-200].
    Gronda E; Sacchi S; Vanoli E
    Int J Cardiol; 2018 Nov; 271():404. PubMed ID: 30025652
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis. The EndoSCORE". [Int. J. Cardiol. 241 (Aug 15 2017) 97-102].
    Di Mauro M; Dato GMA; Barili F; Gelsomino S; Santè P; Corte AD; Carrozza A; Ratta ED; Cugola D; Galletti L; Devotini R; Casabona R; Santini F; Salsano A; Scrofani R; Antona C; Botta L; Russo C; Mancuso S; Rinaldi M; De Vincentiis C; Biondi A; Beghi C; Cappabianca G; Tarzia V; Gerosa G; De Bonis M; Pozzoli A; Nicolini F; Benassi F; Rosato F; Grasso E; Livi U; Sponga S; Pacini D; Di Bartolomeo R; DeMartino A; Bortolotti U; Onorati F; Faggian G; Lorusso R; Vizzardi E; Di Giammarco G; Marinelli D; Villa E; Troise G; Picichè M; Musumeci F; Paparella D; Margari V; Tritto F; Damiani G; Scrascia G; Zaccaria S; Renzulli A; Serraino G; Mariscalco G; Maselli D; Foschi M; Parolari A; Nappi G;
    Int J Cardiol; 2018 May; 258():337. PubMed ID: 29398138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.